Urethral cancer
Urethral cancer is a urothelial tumor and is relatively rare in clinical practice. About 50% of urethral cancers are secondary to transitional cell carcinoma of the bladder, ureter or renal pelvis. Primary urethral cancer is relatively rare and mainly occurs in women. Most male urethral cancers occur in people over 40 years old, while female urethral cancer is more common in middle-aged and elderly people.
-
Site of disease:
Urethra -
Infectious :
Not contagious -
Frequent population:
Most male urethral cancers occur in people over 40 years old... -
Related symptoms:
Funnel-like changes in the internal opening of the urethra Diffuse urethral infiltration Urethra nodules Urethra bleeding Weight loss -
Concurrent disease:
Related Drugs
Doxifluridine Capsules
Indication: This product is used to treat breast cancer, gastric cancer, colorectal cancer, nasopharyngeal cancer, and cervical cancer.
Manufacturer:
Zibo Wanjie Pharmaceutical Co., Ltd.
Doxifluridine Capsules
Indication: This product is used to treat breast cancer, gastric cancer, colorectal cancer, nasopharyngeal cancer, and cervical cancer.
Manufacturer:
Zhejiang Medicine Co., Ltd.
Recombinant human interleukin-2 (Ⅰ) for injection
Indication: Used for the treatment of congenital or acquired immunodeficiency, improving the patient's cellular immune function and anti-infection ability. Treatment of various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, etc. It has a certain therapeutic effect on certain viral, bacillary diseases, and intracellular parasitic infectious diseases, such as hepatitis B, leprosy, tuberculosis, and Candida albicans infection. Used in combination with chemotherapy and radiotherapy to enhance the therapeutic effect and improve immunity. Used for anti-recurrence and anti-metastasis treatment after surgery, chemotherapy and radiotherapy of malignant tumors, and at the same time enhance immunity. Treat malignant pleural, abdominal and pericardial effusions. Used for biological immunotherapy of tumors that are not suitable for surgery, chemotherapy and radiotherapy.
Manufacturer:
Beijing Shougang Gas Company Limited
Recombinant human interleukin-2 (Ⅰ) for injection
Indication: Used for the treatment of congenital or acquired immunodeficiency, improving the patient's cellular immune function and anti-infection ability. Treatment of various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, etc. It has a certain therapeutic effect on certain viral, bacillary diseases, and intracellular parasitic infectious diseases, such as hepatitis B, leprosy, tuberculosis, and Candida albicans infection. Used in combination with chemotherapy and radiotherapy to enhance the therapeutic effect and improve immunity. Used for anti-recurrence and anti-metastasis treatment after surgery, chemotherapy and radiotherapy of malignant tumors, and at the same time enhance immunity. Treat malignant pleural, abdominal and pericardial effusions. Used for biological immunotherapy of tumors that are not suitable for surgery, chemotherapy and radiotherapy.
Manufacturer:
Beijing Shougang Gas Company Limited
Related Ingredients